
GlaxoSmithKline is looking to make more than £7 billion by selling off its ageing portfolio of established drugs. This is …
China has unveiled yet another round of price cuts to prescription medicines. The price cuts cover more than 200 formulations …
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer

